Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Nat Genet ; 53(11): 1553-1563, 2021 11.
Article de Anglais | MEDLINE | ID: mdl-34663923

RÉSUMÉ

Esophageal squamous cell carcinoma (ESCC) shows remarkable variation in incidence that is not fully explained by known lifestyle and environmental risk factors. It has been speculated that an unknown exogenous exposure(s) could be responsible. Here we combine the fields of mutational signature analysis with cancer epidemiology to study 552 ESCC genomes from eight countries with varying incidence rates. Mutational profiles were similar across all countries studied. Associations between specific mutational signatures and ESCC risk factors were identified for tobacco, alcohol, opium and germline variants, with modest impacts on mutation burden. We find no evidence of a mutational signature indicative of an exogenous exposure capable of explaining differences in ESCC incidence. Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like (APOBEC)-associated mutational signatures single-base substitution (SBS)2 and SBS13 were present in 88% and 91% of cases, respectively, and accounted for 25% of the mutation burden on average, indicating that APOBEC activation is a crucial step in ESCC tumor development.


Sujet(s)
Tumeurs de l'oesophage/épidémiologie , Tumeurs de l'oesophage/génétique , Carcinome épidermoïde de l'oesophage/épidémiologie , Carcinome épidermoïde de l'oesophage/génétique , Mutation , APOBEC Deaminases/génétique , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Aldehyde dehydrogenase, mitochondrial/génétique , Brésil/épidémiologie , Chine/épidémiologie , Femelle , Humains , Incidence , Iran/épidémiologie , Mâle , Adulte d'âge moyen , Protéine p53 suppresseur de tumeur/génétique , Royaume-Uni/épidémiologie , Séquençage du génome entier
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE